The main reason for this week's decline is that Moderna lowered its 2025 full-year revenue guidance, and by a wide margin.

CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...

Dame Tracey Emin and Sir Grayson Perry are celebrated with solo exhibitions at the suitably palatial Palazzo Strozzi in ...

The research team at Senders Pediatrics is working with Moderna to study a vaccine developed for Epstein-Barr Virus, which causes mono.

Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. Read more at straitstimes.com.

N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

Plus: Blue Origin and SpaceX launch big rockets, how magnets could guide lasers to make better computers, how to best work ...

The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...

Arbutus Biopharma Corporation (NASDAQ: ABUS) has unveiled its strategic objectives for 2025 alongside an encouraging ...